Ionis Pharmaceuticals (IONS) Misses Q4 EPS by $2.72, Revenues Beat; Offers FY21 Revenue Guidance Below Consensus

Go back to Ionis Pharmaceuticals (IONS) Misses Q4 EPS by $2.72, Revenues Beat; Offers FY21 Revenue Guidance Below Consensus
(NASDAQ: IONS) Delayed: 75.89 --0 (-0%)
Previous Close $75.89    52 Week High $62.68 
Open $75.89    52 Week Low $19.59 
Day High $75.89    P/E N/A 
Day Low $75.89    EPS $0.00 
Volume 278